Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

BNTC Stock Forecast, Price Targets, Chart, Dividends & Analysis

Benitec Biopharma Limited logo

Benitec Biopharma Limited

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

10.92
 
USD
  
0.41
  
(3.90%)
Previous close: 10.51  Open: 10.4856  Bid: 10.4  Ask: 10.93
52 week range    
2.69   
   12.89
Mkt Cap: 114 M  Avg Vol (90 Days): 28,924
Peers   
NWBO / 
NYMX / 
OHCS / 
Last updated: Monday 4th November 2024

Stock Rankings

60
Value
31
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NWBO

NYMX

0.2

OHCS

OMIC

0 B013.46
Financials

BNTC Income Statement

Annual
Invalid dateJun-18Jun-19Jun-20Jun-21Jun-22Jun-23
Basic EPS from continuing operations-137.7-54.91-37.91-14.12
Basic EPS total-0.060.02-137.7-54.91-37.91-14.12
Basic weighted shares outstanding210 M257 M60070.0252671.0480687.01 M
CommissionExpenses662000.0
Depreciation194000.0221000.0190000.0231000.0167000.0136000.0
Depreciation unreconciled194000.0221000.0
DepreciationAndAmortization194000.0221000.0190000.0231000.0167000.0136000.0
Diluted EPS total-0.060.02-137.7-54.91-37.91-14.12
Diluted normalized net income/share-37.91-14.12
Diluted weighted shares outstanding194 M200 M60070.0480687.01 M
GainOnSaleOfPPE-1000.0-9000.0
GainOnSaleOfSecurity-1000.016000.0-11000.0-3000.0
GeneralAndAdministrativeExpense587000.0648000.06 M7 M7 M6 M
Gross operating profit315000.016 M102000.059000.073000.075000.0
Income before tax-12 M4 M-9 M-14 M-18 M-20 M
Interest income242000.0170000.062000.0-6000.0-32000.0-33000.0
MiscOtherSpecialCharges4 M1 M39000.037000.0-79000.0-30000.0
Net income from total operations-12 M4 M-8 M-14 M-18 M-20 M
NetIncomeCommonStockholders-12 M4 M-8 M-14 M-18 M-20 M
NetIncomeContinuousOperations-12 M4 M-8 M-14 M-18 M-20 M
NetNonOperatingInterestIncomeExpense242000.0170000.062000.0-6000.0-32000.0-33000.0
Normalized income-11 M-14 M-15 M
Operating income-15 M3 M-8 M-14 M-18 M-19 M
Operating income before depreciation (EBITDA)-11 M4 M-8 M-13 M-18 M-19 M
OperatingExpense16 M14 M8 M14 M18 M19 M
Other income net-3 M-1 M-38000.0-53000.090000.033000.0
OtherGandA587000.0648000.06 M7 M7 M6 M
OtherOperatingExpenses2 M3 M185000.0-123000.0-9000.0
OtherWriteDown783000.0
RealizedCapitalGain-63000.0
RentAndLandingFees587000.0648000.0
Research & development expense7 M3 M3 M7 M11 M13 M
ResearchExpense7 M3 M3 M7 M11 M13 M
Revenue per share184000.0193000.0225000.0245000.0
SalariesAndWages6 M6 M-34000.0
Selling Gen & administrative expense1 M2 M6 M7 M7 M6 M
SellingAndMarketingExpense468000.01 M
Total Income available for interest expense (EBIT)-12 M4 M-9 M-14 M-18 M-20 M
Total common shares outstanding257 M257 M1 M480687.0480687.03 M
Total net income-12 M4 M-8 M-14 M-18 M-20 M
Total ordinary shares9 M9 M9 M9 M9 M9 M
Total revenues315000.016 M97000.059000.073000.075000.0
TotalExpenses16 M14 M8 M14 M18 M19 M
TotalRevenue378000.016 M102000.059000.073000.075000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University